John V. Heymach

Dr. Heymach joined the MD Anderson faculty in 2005 as an assistant professor, with a joint appointment in Thoracic/Head and Neck Medical Oncology and Cancer Biology. He was promoted to associate professor in 2009. He received his undergraduate degree from Harvard University and both his MD and PhD from Stanford University Medical School in California. He then completed his internship and residency at Brigham and Women’s Hospital and his fellowship in Medical Oncology at Dana-Farber Cancer Institute. During his fellowship, Dr. Heymach worked in the prestigious laboratory of Dr. Judah Folkman with clinical mentorship under Dr. Bruce Johnson.

Dr. Heymach's research focuses on investigating mechanisms of therapeutic resistance, understanding the regulation of angiogenesis in lung cancer, and developing biomarkers for selecting patients most likely to benefit from targeted agents. Dr. Heymach has led a number of Phase I/II clinical trials in NSCLC and currently serves as the principal investigator on the BATTLE-frontline trial using novel combinations of targeted agents as frontline therapy for NSCLC patients. His work has been extensively published in prominent peer-reviewed journals.